Olanzapine is a second-generation antipsychotic, acting on dopamine, serotonin, histamine, muscarinic and adrenergic receptors. It is licensed for schizophrenia and for mania and maintenance in bipolar disorder. In comparative analyses it sits among the more effective antipsychotics - and it also causes more weight gain and metabolic disturbance than almost any of them. Both halves of that are well established, and both belong in the decision.
Follow the plan your prescriber gave you. This guide contains no doses. Do not stop it abruptly.
The metabolic cost
Weight gain on olanzapine is common, can be substantial, and tends to happen early - much of it in the first few months.
Alongside it come raised blood glucose, raised triglycerides and cholesterol, and an increased risk of developing type 2 diabetes. These are not merely consequences of the weight gain; olanzapine appears to affect glucose and lipid handling directly.
People with severe mental illness already have a life expectancy substantially shorter than the general population, largely through cardiovascular disease - so this is not a cosmetic concern.
See medicines and your weight and fenofibrate.
Monitoring that must happen
Weight and waist circumference, blood pressure and pulse, fasting glucose or HbA1c, lipids, liver function and a full blood count - before starting, at intervals through the first year, then at least annually.
Weight should be checked frequently in the early months, when most of the gain occurs and when intervention is most effective.
An ECG is advised where there are cardiac risk factors or other QT-prolonging medicines.
This monitoring is often not done, particularly when prescribing is shared between services. If you have been on olanzapine for a year without any of these checks, ask - see monitoring long-term medicines.
What can be done about the weight
Structured lifestyle intervention started at the same time as the medicine works considerably better than trying to reverse gain later, and referral is reasonable to ask for.
Metformin has evidence for limiting antipsychotic-induced weight gain and is sometimes added - see metformin.
Switching to an antipsychotic with a lower metabolic burden - aripiprazole, for instance - is an option, though it carries a risk of relapse and is a specialist decision.
The thing not to do is stop on your own because of the weight. Relapse in psychosis carries considerable risk, and there are better routes.
Sedation
Olanzapine is markedly sedating, particularly early. It is usually taken at night for that reason.
The sedation often eases over weeks but can persist. Do not drive until you know how it affects you - see medicines and driving. Alcohol adds to it.
For someone acutely unwell and unable to sleep, that sedation is part of why olanzapine is useful in the short term.
Movement effects
Olanzapine causes fewer movement problems than older antipsychotics - less rigidity, tremor and restlessness - though they occur, particularly at higher doses.
Report any involuntary movement of the face or tongue, which can indicate tardive dyskinesia, and inner restlessness or inability to keep still, which is akathisia and is frequently mistaken for anxiety.
Seek urgent help for high fever with muscle rigidity, confusion and sweating - neuroleptic malignant syndrome.
See antipsychotics.
Other effects
Dry mouth, constipation, dizziness on standing and raised prolactin - less than with risperidone but still occurring, causing breast tenderness, milk production and menstrual changes.
Report fever with sore throat or mouth ulcers, which can indicate an effect on white cells.
In older people with dementia, antipsychotics raise the risk of stroke and death, and olanzapine is not licensed for that use.
Orodispersible and depot forms
An orodispersible tablet dissolves on the tongue, useful where swallowing is difficult or where adherence is uncertain.
A long-acting depot injection exists, but it carries a specific risk - post-injection delirium sedation syndrome, where a portion enters the bloodstream rapidly causing marked sedation and confusion. People receiving it must be observed for several hours afterwards, which is why it is given in specific settings.
Stopping
Stopping abruptly causes discontinuation symptoms - insomnia, nausea, sweating, agitation - and, more importantly, a substantial risk of relapse.
Any reduction should be gradual and planned with your team. See why you cannot just stop some medicines.
Smoking induces the enzyme that clears olanzapine, so stopping smoking raises levels and the dose may need reviewing - an interaction that is almost never mentioned in smoking cessation. See ropinirole, which shares it.
If you are struggling, Samaritans are free on 116 123, or you can text SHOUT to 85258.
Related reading: Lithium: Monitoring and the Things That Raise It, with more on what medicines are prescribed for in Conditions.